ASCO 2022 Conference Coverage

 

ASCO 2022 Conference Coverage
J

ASCO 2022 on Clinical and Genomic Characteristics of Pts With Durable Benefit From Immune Checkpoint Inhibitors in Advanced NSCLC

By ASCO 2022 Conference Coverage FEATURING Jacob Sands
By ASCO 2022 Conference Coverage FEATURING Jacob Sands
280 views
June 9, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse
Lung
01:24

Lecture Summary - ASCO 2022 Five-Year Survival Outcomes From CheckMa…

ASCO 2022 Conference Coverage

L. Paz-Ares

100 views
10:59

ASCO 2022 Five-Year Survival Outcomes From CheckMate 227: Nivo + Ipi…

ASCO 2022 Conference Coverage

L. Paz-Ares

151 views
01:21

Lecture Summary - ASCO 2022 on the Phase 3 AcceleRET Lung Study: 1L …

ASCO 2022 Conference Coverage

F. de Marinis

28 views
12:27

ASCO 2022 on the Phase 3 AcceleRET Lung Study: 1L Pralsetinib in RET…

ASCO 2022 Conference Coverage

F. de Marinis

184 views
01:08

Lecture Summary - Pralsetinib in Patients (pts) With Advanced or Met…

ASCO 2022 Conference Coverage

L. Wirth

24 views
10:01

ASCO 2022 Updated Data From the ARROW Trial: Pralsetinib in Patients…

ASCO 2022 Conference Coverage

L. Wirth

160 views
01:46

Lecture Summary - ASCO 2022 3-Year Update From CheckMate 9LA: 1L Niv…

ASCO 2022 Conference Coverage

L. Paz-Ares

27 views
09:18

ASCO 2022 3-Year Update From CheckMate 9LA: 1L Nivo + Ipi + 2 Cycles…

ASCO 2022 Conference Coverage

L. Paz-Ares

481 views
26:58

ASCO 2022 Immunotherapy Nuances in Locally Advanced NSCLC

ASCO 2022 Conference Coverage

J. Varlotto

32 views
48

Lecture Summary - ASCO 2022 Immunotherapy Nuances in Locally Advance…

ASCO 2022 Conference Coverage

J. Varlotto

25 views
06:33

ASCO 2022 on Acquired EGFR-Resistant Mutations in NSCLC

ASCO 2022 Conference Coverage

L. Raez

275 views
55

Lecture Summary - ASCO 2022 on Acquired EGFR-Resistant Mutations in …

ASCO 2022 Conference Coverage

L. Raez

15 views
01:06

Lecture Summary - ASCO 2022 on Recurrent SCLC: Can We Change the Par…

ASCO 2022 Conference Coverage

R. Gentzler

17 views
01:28

Lecture Summary - ASCO 2022 on Durvalumab +/- Tremelimumab + Chemo i…

ASCO 2022 Conference Coverage

B. Chul Cho

17 views
07:37

ASCO 2022 on Durvalumab +/- Tremelimumab + Chemo in 1L mNSCLC: AE Ma…

ASCO 2022 Conference Coverage

B. Chul Cho

63 views
05:02

ASCO 2022 on IO and Chemo-IO for NSCLC With Novel Actionable Oncogen…

ASCO 2022 Conference Coverage

L. Mazzeo, M. Occhipinti

188 views
01:09

Lecture Summary - ASCO 2022 Impact of Trilaciclib on Multilineage Ch…

ASCO 2022 Conference Coverage

J. Goldschmidt

19 views
14:23

ASCO 2022 Impact of Trilaciclib on Multilineage Chemo-Induced Myelos…

ASCO 2022 Conference Coverage

J. Goldschmidt

95 views
04:31

ASCO 2022 Predictors of Biomarker Testing Among Pts With mNSCLC

ASCO 2022 Conference Coverage

N. Robert

693 views
06:43

ASCO 2022 on a Phase I, Open-Label, Dose Escalation, Confirmation, a…

ASCO 2022 Conference Coverage

J. Heymach

106 views
01:17

Lecture Summary - ASCO 2022 on a Phase I, Open-Label, Dose Escalatio…

ASCO 2022 Conference Coverage

J. Heymach

16 views
20:37

Taking on Goliath: Targeting KRAS in NSCLC

Jia Luo

1.2K views
07:03

ASCO 2022 on Phase 3 ATLANTIS Trial: Analysis of Patients With Relap…

ASCO 2022 Conference Coverage

A. Navarro

257 views
05:27

ASCO 2022 on Telisotuzumab Vedotin in Advanced c-Met Overexpressing …

ASCO 2022 Conference Coverage

R. Camidge

182 views
52

Lecture Summary - ASCO 2022 Analysis of Patients With Relapsed SCLC …

ASCO 2022 Conference Coverage

A. Navarro

26 views
23

Lecture Summary - ASCO 2022 on Telisotuzumab Vedotin in Advanced c-M…

ASCO 2022 Conference Coverage

R. Camidge

290 views
05:57

ASCO 2022 on TROPION-Lung08: Dato-DXd + Pembro in Treatment-Naïve Ad…

ASCO 2022 Conference Coverage

B. Levy

134 views
01:18

Lecture Summary - ASCO 2022 on ctDNA Shed as a Tool to Select Immune…

ASCO 2022 Conference Coverage

B. Besse

91 views
33

Lecture Summary - ASCO 2022 Combi-TED: A Multicenter Phase II Trial …

ASCO 2022 Conference Coverage

F. Cappuzzo

24 views
04:36

ASCO 2022 Combi-TED: A Multicenter Phase II Trial Evaluating Efficac…

ASCO 2022 Conference Coverage

F. Cappuzzo

65 views
01:01

Lecture Summary - ASCO 2022 on Stereotactic Radiosurgery vs. WBRT in…

ASCO 2022 Conference Coverage

K. Gaebe

48 views
15:49

ASCO 2022 on Stereotactic Radiosurgery vs. WBRT in SCLC and Intracra…

ASCO 2022 Conference Coverage

K. Gaebe

432 views
25

Lecture Summary - ASCO 2022 on KEYVIBE-008: Randomized, Phase 3 Stud…

ASCO 2022 Conference Coverage

J. Sands

46 views
04:05

ASCO 2022 on KEYVIBE-008: Randomized, Phase 3 Study of 1L Vibostolim…

ASCO 2022 Conference Coverage

J. Sands

514 views
24

Lecture Summary - ASCO 2022 on Clinical and Genomic Characteristics …

ASCO 2022 Conference Coverage

J. Sands

21 views
07:37

ASCO 2022 on Clinical and Genomic Characteristics of Pts With Durabl…

ASCO 2022 Conference Coverage

J. Sands

280 views
52

Lecture Summary - ASCO 2022 Three-Year Outcomes and Correlative Anal…

ASCO 2022 Conference Coverage

B. Ricciuti

115 views
07:54

ASCO 2022 Three-Year Outcomes and Correlative Analyses in Patients W…

ASCO 2022 Conference Coverage

B. Ricciuti

324 views
07:00

ASCO 2022 on GEOMETRY-N Trial: Neoadjuvant and Adjuvant Capmatinib i…

ASCO 2022 Conference Coverage

J. Lee

969 views